Toyama University Hospital Comprehensive Cancer Center 

Toyama University Hospital Comprehensive Cancer Center 



Cancer Immunotherapy Center

HOME > Advanced Medical Care & Research Sections > Cancer Immunotherapy Center

Cancer Immunotherapy Center

Cancer immunotherapy has a long history, but the advent of nivolumab and other immune checkpoint inhibitors has helped develop immunotherapy into a major pillar of cancer treatment. Today, while nivolumab is used as a part of everyday treatment with excellent results, the University of Toyama also has research data on new immunotherapy options with the potential to exceed even these results.
At the Cancer Immunotherapy Center, our mission is to take promising subjects of study that are still in the research stage, and provide them to patients as actual immunotherapy.

Next-Generation Cancer Immunotherapy Using Genetically Modified Immune Cells

One particular example is next-generation cancer immunotherapy using genetically modified immune cells. This form of therapy uses next-generation technology to target hematologic malignancies, lung cancer, and kidney cancer that express specific antigens, for enhanced anti-tumor effects and reduced side effects.

Immunotherapy Using T-Cells Genetically Engineered to Express Tumor Antigen Receptors

Another new form of immunotherapy uses T-cells genetically engineered to express tumor antigen receptors. Through this, we select immune cells based on surgical samples removed from patients, enabling us to provide treatment specifically tailored to each individual patient. In addition to these, leading experts in NK cell function, antibody production, and cytokine signaling are hard at work developing new therapies that further build upon our research results to date. Through efforts like these, available only through the University of Toyama, we aim to accept and treat cancer patients from not only Toyama, but from throughout Japan, and even overseas. This is our mission at the Cancer Immunotherapy Center.

About the Comprehensive Cancer Center
Clinical Results
Contact Us
Clinical Departments
Specific Medical Fields
Advanced Breast Cancer Treatment and Breast Reconstruction Center
Pancreas and Biliary Tract Center
Pediatrics, AYA Generation, and Fertility Center
Robotic Surgery Center
Radiotherapy Center
Oncothermia Center
Blood Oncology Center
Head and Neck Oncology Center
Chest Oncology Center
Gastrointestinal Oncology Center
Urological Oncology Center
Gynecological Oncology Center
Sarcoma and Rare Cancer Center
Genetic Oncology Center
Patient Support Fields
Outpatient Chemotherapy Center
Palliative Care Center
Cancer Rehabilitation Center
Cancer Consultation and Support Center
Japanese Oriental Medicine Center
Treatment Support Fields
Regimen Registry Department
In-House Cancer Registry Department
Human Resource Development Department
Cancer Board Department
Biobank Department
Advanced Medical Care & Research Sections
Advanced Medical Development Center
Cancer Genome Medicine Promotion Center
Cancer Immunotherapy Center
Search by Name of Disease
Oral cancer
Head and neck cancer
Gastrointestinal cancer
Esophageal cancer (endoscopic treatment)
Esophageal cancer (robotic surgery)
Gastric cancer
Liver cancer
Colorectal cancer (early treatment)
Colorectal cancer (surgical treatment)
Cancer pain
Lung cancer
Lung cancer, Mediastinal tumor
Breast reconstruction
Cervical cancer
Childhood cancer
Malignant lymphoma
Multiple myeloma

Center director message